Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway
- 4 October 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (45) , 6597-6606
- https://doi.org/10.1038/sj.onc.1204812
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 41 references indexed in Scilit:
- Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage ResponseScience, 1999
- Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient CellsMolecular Cell, 1999
- Ribozymes, genomics and therapeuticsChemistry & Biology, 1999
- BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cellsOncogene, 1998
- Characterization of a carboxy-terminal BRCA1 interacting proteinOncogene, 1998
- Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiationInternational Journal of Cancer, 1998
- BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteinsOncogene, 1998
- Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxelProtein Journal, 1996
- Ordered independent scattering Ordered independentCommunications in Statistics. Stochastic Models, 1996
- Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sitesCell, 1987